Hemant Surgical Industries Limited (HSIL.BO)
- Previous Close
103.50 - Open
104.01 - Bid 103.05 x --
- Ask 105.99 x --
- Day's Range
103.00 - 104.01 - 52 Week Range
88.15 - 146.00 - Volume
4,800 - Avg. Volume
12,214 - Market Cap (intraday)
1.086B - Beta (5Y Monthly) --
- PE Ratio (TTM)
9.18 - EPS (TTM)
11.33 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Hemant Surgical Industries Limited manufactures, markets, imports, and exports medical disposable, surgical equipment, and pharmaceutical products in India and internationally. The company offers healthcare products and medical equipment, including paramonitors, ultrasound machines, and ventilators for critical care and radiology; ECG machines and electrodes for cardiovascular disease; nebulizers for respiratory disease; and hemodialysis machines, dialysis solution acidic and bicarbonate, and dialyzers for renal care. It also provides surgical disposables, such as meditapes, intravenous infusion sets, scalp vein sets, foley catheters, and 3ply masks; and other healthcare products comprising digital thermometers, cold and hot sterilant, dialysis chairs, and 5 function electric ICU beds with mattresses. In addition, the company offers blood transfusion and burette sets; oximeters, anti-decubitus mattresses, and oxygen concentrators; dialysis equipment and consumables; skin grafting blades, skin staplers, and endotracheal ET tubes; anesthesia machines, syringe and infusion pumps, and defibrillators; CR and DR systems, x-ray machines, CT injectors, and mammography and dental machines; diabetic foot care products; and ophthalmology equipment. Further, it provides turnkey dialysis center, imaging and diagnostic center, modular intensive care unit, modular operation theater, oncology labs and treatment centers, blood bank, and dental clinic setup services. Hemant Surgical Industries Limited was founded in 1985 and is headquartered in Mumbai, India.
www.hemantsurgical.comRecent News: HSIL.BO
View MorePerformance Overview: HSIL.BO
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSIL.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSIL.BO
View MoreValuation Measures
Market Cap
1.09B
Enterprise Value
1.15B
Trailing P/E
9.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.02
Price/Book (mrq)
1.87
Enterprise Value/Revenue
1.08
Enterprise Value/EBITDA
7.70
Financial Highlights
Profitability and Income Statement
Profit Margin
8.47%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.07B
Net Income Avi to Common (ttm)
90.59M
Diluted EPS (ttm)
11.33
Balance Sheet and Cash Flow
Total Cash (mrq)
78.24M
Total Debt/Equity (mrq)
24.90%
Levered Free Cash Flow (ttm)
--